
Current asthma guidelines recommend treatment based on the assessment of asthma control using symptoms and lung zzso zzso markers are an attractive way to modify therapy since they offer improved selection of active zzso based on individual response, and improved zzso of treatment using markers that are better related to treatment zzso 

To review the zzso and design features of zzso marker studies in zzso 

zzso assessment of published zzso trials of asthma therapy guided by fraction of zzso zzso zzso 

zzso has appeal as a marker to adjust asthma therapy since it is readily measured, gives zzso results, and is responsive to changes in zzso zzso zzso However, the five zzso trials of zzso guided therapy have had mixed zzso This may be because there are specific design and zzso issues that need to be addressed in the conduct of zzso zzso zzso zzso There needs to be a clear dose response relationship for the active drugs used and the outcomes zzso The zzso decision points should be based on outcomes in the population of interest rather than the range of values in healthy people, and the zzso used needs to provide a sufficiently different result to clinical decision making in order for there to be any discernible zzso A new metric is required to assess the zzso performance, and the zzso ratio can assist with zzso 

zzso these design features into future zzso studies should improve the study performance and aid in obtaining a better estimate of the value of zzso guided asthma zzso 

